Search results
Results from the WOW.Com Content Network
File:COVID-19 Vaccination Record Card CDC (8-17-2020).pdf. Size of this JPG preview of this PDF file: 710 × 599 pixels. Other resolutions: 284 × 240 pixels | 569 × 480 pixels | 725 × 612 pixels. This is a file from the Wikimedia Commons. Information from its description page there is shown below. Commons is a freely licensed media file ...
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [32] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. [44] [45] It is authorized for use ...
Abdala, technical name CIGB-66, is a COVID-19 vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba. [1] This candidate, named after a patriotic drama by Cuban independence hero José Martí, is a protein subunit vaccine containing COVID-derived proteins that trigger an immune response. [2]
Vaccination in Denmark is free of cost and voluntary. [1] It is available to all residents of Denmark and those from abroad staying for more than 30 days in Denmark. [1] Denmark has one of the highest levels of COVID-19 vaccination in the European Union as of the end of September 2021. [2] In April 2022, Denmark announced the suspension of its ...
Companies manufacturing Covid vaccines for the US have set their price lists, and each dose will be between $120 and $130, according to reporting from Reuters. Pfizer and BioNTech set their price ...
The Sanofi–GSK COVID‑19 vaccine is a recombinant protein subunit vaccine containing the SARS-CoV-2 spike protein, which is produced in insect cells via a baculovirus vector. It also includes an adjuvant made by GSK. It uses the same technology as Sanofi's Flublok influenza vaccine. [7] [8]
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in ...
Pfizer and Moderna make messenger RNA vaccines, which can be developed more quickly than Novavax's protein-based shot. The JN.1 variant was the dominant strain in the United States earlier this year.